Clinical features associated with medically unexplained stroke-like symptoms presenting to an acute stroke unit

European Journal of Neurology

Volumn 12, Issue 2, 2005, Pages 81-85

  Nazir, F S ^a,c   Lees, K R ^a   Bone, I ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b INSTITUTE OF NEUROLOGICAL SCIENCES   (United Kingdom)

^c SOUTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cerebrovascular accident diagnosis; Conversion disorder; Regression analysis; Retrospective studies

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ANXIETY; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; DYSPEPSIA; FACE PAIN; FEMALE; FIBROMYALGIA; HEADACHE; HUMAN; HYPERVENTILATION SYNDROME; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MULTIPLE CHEMICAL SENSITIVITY; PELVIS PAIN SYNDROME; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; STROKE; SYMPTOM; THORAX PAIN; TRANSIENT ISCHEMIC ATTACK;

CEREBROVASCULAR ACCIDENT; FEMALE; HOSPITAL UNITS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 13844310349     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2004.01010.x     Document Type: Article

References (25)

1. Anonymous (2001). Consensus opinion: what to do about medically unexplained symptoms. Drugs Ther. Bull. 39:5-8.
2. Carson AJ, Ringbauer B, Stone J, McKenzie L, Warlow C, Sharpe M (2000). Do medically unexplained symptoms matter? A prospective cohort study of 300 new referrals to neurology outpatient clinics. J. Neurol. Neurosurg. Psychiatry 68:207-210.
3. Crimlisk HL, Bhatia K, Cope H, David A, Marsden CD, Ron MA (1998). Slater revisited: 6 year follow up study of patients with medically unexplained motor symptoms. BMJ 316:582-586.
4. Dula DJ, DeNaples L (1995). Emergency department presentation of patients with conversion disorder. Acad. Emerg. Med. 2:120-123.
5. Garcia-Monco JC, Marrodan A, Foncea BN, Gomez BM (2002). Stroke and transient ischemic attack-mimicking conditions: a prospective analysis of risk factors and clinical profiles at a general hospital. Neurologia 17:355-360.
6. Hadjiev DI, Mineva PP, Vukov MI (2003). Multiple modifiable risk factors for first ischemic stroke: a population-based epidemiological study. Eur. J. Neurol. 10:577-582.
7. Hamilton J, Campos R, Creed F (1996). Anxiety, depression and management of medically unexplained symptoms in medical clinics. J. R. Coll. Phys. Lond. 30:18-20.
8. Isles CG, Walker LM, Beevers GD et al. (1986). Mortality in patients of the Glasgow Blood Pressure Clinic. J. Hypertens. 4:141-156.
9. Kendrick S, Clarke J (1993). The Scottish Record Linkage System. Health Bull. (Edinb.) 51:72-79.
10. Kothari RU, Brott T, Broderick JP, Hamilton CA (1995). Emergency physicians. Accuracy in the diagnosis of stroke. Stroke 26:2238-2241.
11. Kroenke K, Swindle R (2000). Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother. Psychosom. 69:205-215.
12. Libman RB, Wirkowski E, Alvir J, Rao TH (1995). Conditions that mimic stroke in the emergency department. Implications for acute stroke trials. Arch. Neurol. 52:1119-1122.
13. Mayou R, Bryant B, Forfar C, Clark D (1994). Non-cardiac chest pain and benign palpitations in the cardiac clinic. Br. Heart J. 72:548-553.
14. Nimnuan C, Hotopf M, Wessely S (2001a). Medically unexplained symptoms: an epidemiological study in seven specialities. J. Psychosom. Res. 51:361-367.
15. Nimnuan C, Rabe-Hesketh S, Wessely S, Hotopf M (2001b). How many functional somatic syndromes? J. Psychosom. Res. 51:549-557.
16. O'Malley PG, Balden E, Tomkins G, Santoro J, Kroenke K, Jackson JL (2000). Treatment of fibromyalgia with antidepressants: a meta-analysis. J. Gen. Intern. Med. 15:659-666.
17. Scott PA, Silbergleit R (2003). Misdiagnosis of stroke in tissue plasminogen activator-treated patients: characteristics and outcomes. Ann. Emerg. Med. 42:611-618.
18. Sharpe M (2002). Medically unexplained symptoms and syndromes. Clinical medicine. J. R. Coll. Phys. 2:501-504.
19. Shaw J, Creed F (1991). The cost of somatization. J. Psychosom. Res. 35:307-312.
20. Stone J, Sharpe M, Carson A et al. (2002a). Are functional motor and sensory symptoms really more frequent on the left? A systematic review. J. Neurol. Neurosurg. Psychiatry 73:578-581.
21. Stone J, Zeman A, Sharpe M (2002b). Functional weakness and sensory disturbance. J. Neurol. Neurosurg. Psychiatry 73:241-245.
22. Stone J, Sharpe M, Rothwell PM, Warlow CP (2003). The 12 year prognosis of unilateral functional weakness and sensory disturbance. J. Neurol. Neurosurg. Psychiatry 74:591-596.
23. The West of Scotland Coronary Prevention Study Group (1995). Computerised record linkage: compared with traditional patient follow-up methods in clinical trials and illustrated in a prospective epidemiological study. J. Clin. Epidemiol. 48:1441-1445.
24. Tomkins GE, Jackson JL, O'Malley PG, Balden E, Santoro JE (2001). Treatment of chronic headache with antidepressants: a meta-analysis. Am. J. Med. 111:54-63.
25. Wessely S, Nimnuan C, Sharpe M (1999). Functional somatic syndromes: one or many? Lancet 354:936-939.